Glucosalina

Glucosalina is an intravenous solution containing sodium chloride and glucose. It is supplied in a sterile liquid form for infusion, with no specified strength listed. The product is manufactured for the European Union market and is intended for use under professional medical supervision. The formulation provides electrolytes and an energy source, and it is typically stored at controlled room temperature until administration in clinical settings by healthcare professionals.

Glucosalina is used as an intravenous fluid to support patients who require electrolyte replacement and an energy substrate during medical treatment. Its typical clinical applications include: - Rehydration therapy for patients with fluid loss. - Maintenance of plasma volume during surgery. - Supplementation of sodium and chloride in patients with electrolyte imbalance. - Provision of glucose for patients unable to intake oral carbohydrates. - Dilution and carrier solution for intravenous drug administration.

Potential adverse effects of Glucosalina may vary in frequency and severity. Reported events are categorized as common or serious based on clinical observations.

Common: - Mild injection site irritation or redness. - Transient nausea or vomiting. - Temporary increase in blood glucose levels.

Serious: - Hypernatremia or electrolyte imbalance. - Severe allergic reaction such as anaphylaxis. - Fluid overload leading to pulmonary edema.

When considering Glucosalina, clinicians should evaluate patient-specific factors and follow standard infusion guidelines to minimize risk. - Assess baseline electrolyte levels and renal function before administration. - Monitor blood glucose and serum sodium during infusion. - Adjust infusion rate in patients with heart failure or pulmonary edema risk. - Avoid rapid infusion in neonates and infants. - Use aseptic technique to prevent contamination. - Discontinue if signs of allergic reaction appear.

Glucosalina may interact with other intravenous solutions or medications, influencing electrolyte balance or glucose metabolism.

Avoid: - Co-administration with hypertonic saline solutions without adjusting total sodium load. - Simultaneous infusion of high-concentration dextrose solutions that could cause hyperglycemia.

Use with caution: - Concurrent use of diuretics that affect sodium balance. - Patients receiving insulin therapy, requiring close glucose monitoring. - Administration alongside nephrotoxic drugs, monitoring renal function.